scholarly article | Q13442814 |
P356 | DOI | 10.12688/F1000RESEARCH.7071.1 |
P8608 | Fatcat ID | release_iynif3cni5gg3eiu6taz4yhjbu |
P932 | PMC publication ID | 4754031 |
P698 | PubMed publication ID | 26918152 |
P2093 | author name string | Joseph Berger | |
Laura Adang | |||
P2860 | cites work | Spinal cord progressive multifocal leukoencephalopathy detected premortem by MRI. | Q53442107 |
Relapse rates and enhancing lesions in a phase II trial of natalizumab in multiple sclerosis. | Q53655424 | ||
Clinical outcomes of natalizumab-associated progressive multifocal leukoencephalopathy | Q84114256 | ||
Progressive multifocal leukoencephalopathy | Q87387869 | ||
Treatment-related progressive multifocal leukoencephalopathy: current understanding and future steps | Q26823444 | ||
PML diagnostic criteria: consensus statement from the AAN Neuroinfectious Disease Section | Q30613846 | ||
Infection risk in patients on multiple sclerosis therapeutics | Q30908652 | ||
Progressive Multifocal Leukoencephalopathy: Recent Advances and a Neuro-Ophthalmological Review. | Q30978105 | ||
Progressive multifocal leukoencephalopathy in patients with HIV infection | Q32073645 | ||
Cultivation of papova-like virus from human brain with progressive multifocal leucoencephalopathy | Q34201921 | ||
Risk of natalizumab-associated progressive multifocal leukoencephalopathy | Q34275329 | ||
Progressive multifocal leukoencephalopathy: why gray and white matter | Q34307762 | ||
Progressive multifocal leuko-encephalopathy; a hitherto unrecognized complication of chronic lymphatic leukaemia and Hodgkin's disease | Q34538727 | ||
Clinical outcome of long-term survivors of progressive multifocal leukoencephalopathy | Q34802752 | ||
Anti-JC virus antibody levels in serum or plasma further define risk of natalizumab-associated progressive multifocal leukoencephalopathy. | Q34803324 | ||
Hyperintense cortical signal on magnetic resonance imaging reflects focal leukocortical encephalitis and seizure risk in progressive multifocal leukoencephalopathy | Q35590449 | ||
Predictors of survival and functional outcomes in natalizumab-associated progressive multifocal leukoencephalopathy | Q36234255 | ||
Progressive multifocal leukoencephalopathy: electron microscope study of four cases | Q36566737 | ||
Pathogenesis of progressive multifocal leukoencephalopathy--revisited | Q37828002 | ||
JC virus granule cell neuronopathy: A cause of infectious cerebellar degeneration | Q41205934 | ||
Anti-JC virus (JCV) antibody prevalence in the JCV Epidemiology in MS (JEMS) trial | Q42214743 | ||
Continued declining incidence and improved survival of progressive multifocal leukoencephalopathy in HIV/AIDS patients in the current era. | Q42251011 | ||
Epidemiology and prognosis of AIDS-associated progressive multifocal leukoencephalopathy in the HAART era. | Q44527255 | ||
Incidence, clinical presentation, and outcome of progressive multifocal leukoencephalopathy in HIV-infected patients during the highly active antiretroviral therapy era: a nationwide cohort study | Q48828618 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P407 | language of work or name | English | Q1860 |
P921 | main subject | progressive multifocal leukoencephalopathy | Q704930 |
P577 | publication date | 2015-01-01 | |
P1433 | published in | F1000Research | Q27701587 |
P1476 | title | Progressive Multifocal Leukoencephalopathy | |
P478 | volume | 4 |
Q47555504 | Detection and analysis of variants of JC polyomavirus in urine samples from HIV-1-infected patients in China's Zhejiang Province |
Q39046213 | Drug-induced progressive multifocal leukoencephalopathy in multiple sclerosis: European regulators' perspective |
Q99712209 | Infections in the Era of Targeted Therapies: Mapping the Road Ahead |
Q57471145 | Low Frequency of Opportunistic Infections in Patients Receiving Vedolizumab in Clinical Trials and Post-Marketing Setting |
Q61800800 | Not All Strokes Are Strokes An Example of Diagnostic Confirmation Bias |
Q30245002 | Progressive Multifocal Leukoencephalopathy in HIV-Uninfected Individuals. |
Q91830971 | Progressive Multifocal Leukoencephalopathy: Current Insights |
Q39034482 | Reducing persistent polyomavirus infection increases functionality of virus-specific memory CD8 T cells |
Q52580360 | What Is the Risk of Progressive Multifocal Leukoencephalopathy in Patients With Ulcerative Colitis or Crohn's Disease Treated With Vedolizumab? |